Financial hardship tied to cancer treatments

Historically, cancer has been one of the most costly medical conditions to treat in the United States. Compared to a decade ago, cancer patients are receiving increasingly expensive chemotherapy and biologics, both alone and in combination. The use of expensive supportive agents and hematopoietic growth factors has also increased. The cost of newly introduced chemotherapy and supportive drug-based treatments is growing, and prices higher than $10,000 a month for individual drugs and biologic agents are common.
High out-of pocket costs, loss of productivity, medical debt and depletion of assets, all cause severe hardship (financial toxicity) for patients and their families.

Read more: https://www.cancer.gov/about-cancer/managing-care/financial-toxicity-hp-pdq#link/_1